In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 49 for your search:
Drug:  sirolimus
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Prevention
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 0468H1-407, NCT00129961
2.

Phase: Phase IV
Type: Prevention
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: PROSKIN 01, NCT00866684
3.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: Other
Protocol IDs: #4279, NCT00328770
4.

Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 to 80
Sponsor: Other
Protocol IDs: 2003.333, NCT00133887
5.

Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: SiLVER05, EudraCT Number:, 2005-005362-36, NCT00355862
6.

Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 2 to 55
Sponsor: NCI, NHLBI
Protocol IDs: 385, BMT CTN 0402, U01 HL069294-05, NCT00406393
7.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: RDCRN 5702, RLD 5702, 1 U54 RR019498-01, NCT00414648
8.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000257255, P30CA016042, UCLA-0203078, NCI-G02-2114, NCT00047073
9.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000557423, P30CA016042, UCLA-0604104, OSI3781s, NCT00509431
10.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: 080078, 08-C-0078, NCT00923273
11.

Phase: Phase II, Phase I
Type: Supportive care
Status: Completed
Age: Per primary treatment protocol
Sponsor: NCI, Other
Protocol IDs: 1811.00, FHCRC-1811.00, CDR0000378004, NCT00089037
12.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 4 to 35
Sponsor: NCI
Protocol IDs: 020259, 02-C-0259, NCI-02-C-0259, NCT00047372, NCT00043979
13.

Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: 1938.00, NCI-2010-00268, P01HL036444, P01CA018029, FHCRC-1938.00, 5887, NCT00105001
14.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 65
Sponsor: NCI, Other
Protocol IDs: CDR0000440080, DFCI-04298, WYETH-C-0468H1-101899, NCT00126672
15.

Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: 18 to 65
Sponsor: Other
Protocol IDs: 05-154, NCT00133367
16.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 60 and over
Sponsor: Other
Protocol IDs: 0402008, GOELAMS, PHRC, NCT00235560
17.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: JHOC-J0507, CDR0000455000, P30CA006973, JHOC-J0507, JHOC-05041402, J0507, NCT00276744
18.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 05-1135, NCT00353301
19.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: JHOC-J0415, CDR0000549899, P30CA006973, JHOC-J0415, JHOC-04-06-16-01, J0415, NCT00499486
20.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 65
Sponsor: Other
Protocol IDs: TESSTAL, NCT00490789
21.

Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: 01089, P30CA033572, CHNMC-01089, CDR0000566376, NCT00544115
22.

Phase: Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 2 and over
Sponsor: NCI, Other
Protocol IDs: 06141, P30CA033572, CHNMC-06141, CDR0000579340, NCT00589563
23.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 3 and over
Sponsor: NCI
Protocol IDs: 080096, 08-C-0096, NF-102, NCI-08-C-0096, NCT00652990
24.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 00000345, NCT00672243
25.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000597130, P30CA022453, WSU-2007-127, GENZ-WSU-2007-127, 2007-127, NCT00691015
1   
New Search